COMPUGROUP MEDSPADR Valuation
| COPA Stock | EUR 20.80 0.20 0.97% |
At this time, the firm appears to be overvalued. COMPUGROUP MEDSPADR shows a prevailing Real Value of €18.98 per share. The current price of the firm is €20.8. Our model approximates the value of COMPUGROUP MEDSPADR from reviewing the firm fundamentals such as return on equity of 0.11, and Profit Margin of 0.06 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that COMPUGROUP MEDSPADR's price fluctuation is somewhat reliable at this time. Calculation of the real value of COMPUGROUP MEDSPADR is based on 3 months time horizon. Increasing COMPUGROUP MEDSPADR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the COMPUGROUP stock is determined by what a typical buyer is willing to pay for full or partial control of COMPUGROUP MEDSPADR 1. Since COMPUGROUP MEDSPADR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of COMPUGROUP Stock. However, COMPUGROUP MEDSPADR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.8 | Real 18.98 | Hype 20.8 |
The real value of COMPUGROUP Stock, also known as its intrinsic value, is the underlying worth of COMPUGROUP MEDSPADR Company, which is reflected in its stock price. It is based on COMPUGROUP MEDSPADR's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of COMPUGROUP MEDSPADR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of COMPUGROUP MEDSPADR 1 helps investors to forecast how COMPUGROUP stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of COMPUGROUP MEDSPADR more accurately as focusing exclusively on COMPUGROUP MEDSPADR's fundamentals will not take into account other important factors: COMPUGROUP MEDSPADR Total Value Analysis
COMPUGROUP MEDSPADR 1 is currently projected to have takeover price of 0 with market capitalization of 2.72 B, debt of 685.04 M, and cash on hands of 91.45 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the COMPUGROUP MEDSPADR fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 2.72 B | 685.04 M | 91.45 M |
COMPUGROUP MEDSPADR Investor Information
The company last dividend was issued on the 20th of May 2022. Based on the analysis of COMPUGROUP MEDSPADR's profitability, liquidity, and operating efficiency, COMPUGROUP MEDSPADR 1 is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.COMPUGROUP MEDSPADR Asset Utilization
One of the ways to look at asset utilization of COMPUGROUP is to check how much profit was generated for every dollar of assets it reports. COMPUGROUP MEDSPADR 1 utilizes its assets nearly 0.031 percent, getting 0.031 cents for each euro of assets held by the firm. An expanding asset utilization signifies that the company is being more capable with each euro of assets it shows. Put another way, asset utilization of COMPUGROUP MEDSPADR shows how capable it operates for each euro spent on its assets.COMPUGROUP MEDSPADR Profitability Analysis
The company reported the revenue of 1.13 B. Net Income was 72.32 M with profit before overhead, payroll, taxes, and interest of 373.55 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates COMPUGROUP MEDSPADR's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in COMPUGROUP MEDSPADR and how it compares across the competition.
About COMPUGROUP MEDSPADR Valuation
The stock valuation mechanism determines COMPUGROUP MEDSPADR's current worth on a weekly basis. Our valuation model uses a comparative analysis of COMPUGROUP MEDSPADR. We calculate exposure to COMPUGROUP MEDSPADR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of COMPUGROUP MEDSPADR's related companies.KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. COMPUGROUP MED is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct COMPUGROUP MEDSPADR's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates COMPUGROUP MEDSPADR's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct COMPUGROUP MEDSPADR's valuation analysis, follow these 8 steps:- Gather financial information: Obtain COMPUGROUP MEDSPADR's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine COMPUGROUP MEDSPADR's revenue streams: Identify COMPUGROUP MEDSPADR's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research COMPUGROUP MEDSPADR's industry and market trends, including the size of the market, growth rate, and competition.
- Establish COMPUGROUP MEDSPADR's growth potential: Evaluate COMPUGROUP MEDSPADR's management, business model, and growth potential.
- Determine COMPUGROUP MEDSPADR's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate COMPUGROUP MEDSPADR's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for COMPUGROUP Stock analysis
When running COMPUGROUP MEDSPADR's price analysis, check to measure COMPUGROUP MEDSPADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COMPUGROUP MEDSPADR is operating at the current time. Most of COMPUGROUP MEDSPADR's value examination focuses on studying past and present price action to predict the probability of COMPUGROUP MEDSPADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COMPUGROUP MEDSPADR's price. Additionally, you may evaluate how the addition of COMPUGROUP MEDSPADR to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |